Literature DB >> 33456174

Catastrophic complications following cryoablation of lung cancer.

Vrinda Vyas1, Manju Paul2.   

Abstract

Image-guided cryoablation has low procedure-related morbidity and mortality rates, with the complications usually being self-limiting. The most common complications include pneumothorax, hemoptysis, pleural effusion, cough, phrenic nerve injury, and tumor implantation. Bronchopleural or bronchocutaneous fistula formation is a rare but severe complication of lung cancer ablation. We report a patient with non-small cell lung cancer who developed a bronchocutaneous fistula, persistent empyema, and chest wall abscess a month after cryoablation. With this case report, we aim to sensitize physicians to such complications.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Bronchocutaneous fistula; empyema; lung cancer; multifocal pneumonia; percutaneous cryoablation; pneumothorax

Year:  2020        PMID: 33456174      PMCID: PMC7785183          DOI: 10.1080/08998280.2020.1830333

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

Review 1.  Mechanisms of tissue injury in cryosurgery.

Authors:  A A Gage; J Baust
Journal:  Cryobiology       Date:  1998-11       Impact factor: 2.487

Review 2.  Percutaneous imaging-guided cryoablation for lung cancer.

Authors:  Yi-Shi Zhang; Li-Zhi Niu; Ke Zhan; Zhong-Hai Li; Yu-Gang Huang; Yi Yang; Ji-Bing Chen; Ke-Cheng Xu
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures.

Authors:  Hongwu Wang; Peter J Littrup; Yunyou Duan; Yanqun Zhang; Huasong Feng; Zhoushan Nie
Journal:  Radiology       Date:  2005-04       Impact factor: 11.105

4.  Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.

Authors:  Alla Zemlyak; William H Moore; Thomas V Bilfinger
Journal:  J Am Coll Surg       Date:  2010-05-26       Impact factor: 6.113

5.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

Review 6.  Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management.

Authors:  Manuel Lois; Marc Noppen
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

7.  Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors.

Authors:  Jun Sakurai; Takao Hiraki; Takashi Mukai; Hidefumi Mimura; Kotaro Yasui; Hideo Gobara; Soichiro Hase; Hiroyasu Fujiwara; Toshihiro Iguchi; Nobuhisa Tajiri; Motoi Aoe; Yoshifumi Sano; Hiroshi Date; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2007-01       Impact factor: 3.464

8.  CT-guided thin needles percutaneous cryoablation (PCA) in patients with primary and secondary lung tumors: a preliminary experience.

Authors:  Claudio Pusceddu; Barbara Sotgia; Rosa Maria Fele; Luca Melis
Journal:  Eur J Radiol       Date:  2013-02-08       Impact factor: 3.528

9.  Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.

Authors:  Yoshikane Yamauchi; Yotaro Izumi; Kohei Hashimoto; Hideki Yashiro; Masanori Inoue; Seishi Nakatsuka; Taichiro Goto; Masaki Anraku; Takashi Ohtsuka; Mitsutomo Kohno; Masafumi Kawamura; Hiroaki Nomori
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

Review 10.  Cryoablation of early-stage primary lung cancer.

Authors:  Masanori Inoue; Seishi Nakatsuka; Masahiro Jinzaki
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

  10 in total
  1 in total

Review 1.  Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors.

Authors:  Arian Mansur; Tushar Garg; Apurva Shrigiriwar; Vahid Etezadi; Christos Georgiades; Peiman Habibollahi; Timothy C Huber; Juan C Camacho; Sherif G Nour; Alan Alper Sag; John David Prologo; Nariman Nezami
Journal:  Diagnostics (Basel)       Date:  2022-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.